Nextbiotix
Biotechnology company tackling the use of commensal bacteria. as drugs.
Launch date
Employees
Market cap
-
Enterprise valuation
€28—42m (Dealroom.co estimates Jul 2018.)
Dijon Bourgogne-Franche-Comté (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | N/A | Spinout |
* | €7.0m | Series A | |
| Total Funding | €7.0m | ||
Related Content
Recent News about Nextbiotix
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.